Survey identifies risk factor for French companies:
This article was originally published in Clinica
One in six French medical device companies is at high risk of failure. That is the conclusion of a financial analysis compiled by UK company Plimsoll Publishing, which added that many companies in this category would struggle to settle payments with overseas suppliers. On the other side of the coin, 238 of this survey of the 350 most important manufacturers and retailers of medical devices are "financially sound and would be ideal companies with whom to do business". For more details of the survey, contact Plimsoll Publishing in Middlesborough, UK. Tel: +44 (0) 1642 257 809. Fax: +44 (0)1642 257 806.
You may also be interested in...
Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.